SVIN26 Annual Meeting - November 17-20, 2026

LATE-BREAKING AND CLINICAL TRIALS ABSTRACT SUBMISSION INSTRUCTIONS

Submissions are now open

Submission deadline: October 5, 2026 11:59 pm EST

Submit Abstract

The Late-Breaking and Clinical Trial Abstract category gives authors the opportunity to share the most current and impactful findings in interventional and stroke care with the SVIN community. Unlike standard abstract submissions, this track is reserved for late-breaking results and clinical trial updates that emerge after the general submission deadline, ensuring that attendees leave the meeting with the most up-to-date science in the field.

Late-Breaking Science: This category is intended for abstracts that significantly influence the future of interventional and stroke care and treatment. They must highlight exceptionally important results obtained after the regular abstract submission deadline.

Clinical Trials: This category is intended for abstracts detailing the rationale and design of clinical trials, as well as updates on eligibility and recruitment for ongoing or recently completed clinical trials or large multicenter registries.

Any abstract that does not fit the above criteria should not be submitted as a Late-Breaking or Clinical Trial abstract and will not be considered for inclusion in the SVIN 2026 program. Abstract notification letters will be delivered at the end of October.

Important Information

Abstract Preparation

The Submission Process

  • All accepted abstracts will be included on the SVIN website and S:VIN Journal.
  • The presenting author must be an author of the abstract.
  • Presenting authors of accepted abstracts will be required to register for and attend the SVIN 2026 Annual Meeting. Registration fees are required and are not waived with acceptance.
  • Authors have the option to submit their abstract for one of the following options:
    • Printed Poster
    • Moderated Poster – Professor Rounds
    • Platform/Oral Presentation
    • Platform or Printed Poster Presentation
    • Online E-Poster
      • There is a maximum of one platform and one poster presentations per presenting author.
  • Presentation preferences will be taken into consideration; however, the Annual Meeting Scientific Program Committee reserves the right to determine the final presentation format.
  • If ‘Platform Presentation Only’ is selected, consideration will not be made for a poster presentation. Similarly, if ‘E-Poster Presentation Only’ is selected, consideration will not be made for a platform presentation.
  • IMPORTANT! SVIN will accept only one platform presentation per presenting author. If one submits more than one abstract for platform presentation, the others will automatically be reviewed for Online E-poster.
  • Avoid trade names when possible. You may use the trade name once, for example - ticagrelor (Brilinta).
  • Please disclose any potential conflict of interests of the ALL the authors in the submission
  • Please ensure that all authors have been submitted with your abstract as you will not be able to add additional authors after the review period begins.
  • No identifying features such as names of hospitals, medical schools, or cities may be listed in the title or text of the abstract.
  • Abstracts previously presented at a national/international meeting may be submitted to SVIN. Please cite the meeting, location, and date of the previous presentation. Abstracts CANNOT be previously published in a manuscript.
  • The title cannot be longer than 15 words but should clearly indicate the nature of the study. Capitalize the first letter of each word within the title.

Abstract Body

  • No identifying features such as names of hospitals, medical schools, cities or patients may be listed in the title or text of the abstract. Do NOT include the names of any of the authors. The names of authors and their affiliations (institutions) will be submitted online during the process.
  • Abstracts should state clearly and briefly the purpose, methods, results and conclusions of the work. There is a strict 500-word limit for the abstract body; each graphic or table counts as 100 words. Please format abstracts using the following headings:
    • Introduction/Purpose: Clearly state the purpose of the study.
    • Materials/Methods: Describe the design of the study clearly.
    • Results: Present your results in a logical sequence.
    • Conclusion: Emphasize new and important aspects of the study and conclusions that are drawn from your results.
  1. To submit an abstract, please visit our online Abstract Submission site and register with the system. If you already have an account, please log in using your existing credentials — you do not need to create a new account. If you do not have an account, click on “Create New Account” and complete the form with the required fields. Once the form is submitted, you will be redirected to the login page. Please be sure to save your login credentials.
     
  2. Log into the system using the username and password you chose. To begin a new submission, select “Submissions” and then “Add New”.
     
  3. Submitting an abstract is a multi-step process. To submit a new abstract, log into the system and click on “Add New”. This will take you through the steps of submitting your abstracts. Be sure to read the directions on each page carefully. There are multiple steps within the abstract submission process:

    Step 1: Title
    Step 2: Category
    Step 3: Presentation Preference
    Step 4: Keyword(s)
    Step 5: Author(s)
    Step 6: Abstract Body
    Step 7: Additional Information
    Step 8: Review and Submit
     
  4. You will select one primary category that your abstract falls within. The categories to choose from are as follows:
    • Aneurysm/Vascular Malformations
    • Basic Science
    • Education
    • Emerging Technology
    • Extracranial Interventions
    • Global Health/Health Equity
    • Imaging
    • Intracranial/Subarachnoid Hemorrhage
    • Intracranial Stenosis
    • Ischemic Stroke – Vascular Neurology
    • Ischemic Stroke – Neurointervention
    • Large Artery Disease
    • Neurocritical Care
    • Other Pathology
    • Stroke Systems of Care
    • Venous Disease and Interventions
       
  5. Questions marked with a red asterisk* are required fields. The system will indicate which of the steps you have not completed when you go to finalize and submit your abstract. You can also save and continue your abstract at a later time, but please ensure it is submitted by the deadline.
     
  6. For each abstract submitted, a maximum of two graphic files or tables is permitted. Ensure file resolution is ≥300 dpi. Please upload file(s) as jpg or gif formats only.
     
  7. Once an abstract has been submitted, additional edits can be made until the abstract deadline. If you wish to delete a submission, you can do so within the ‘Submissions’ window and selecting “Delete” within each listed abstract submission.
     
  8. To submit additional abstracts, select ‘Home’ button in the upper right-hand corner of the screen to return to the ‘Submissions’ window and then select “Add New.” You will need to close out of the current abstract (including reviewing an already submitted abstract) before beginning a new submission.

Contact Information

Questions or concerns with the abstract submission platform?
Email SVIN@support.ctimeetingtech.com or call 217-398-1792

Standard support hours are Monday thru Friday, 8:00 am to 5:00 pm US Central.

1601 Utica Ave S, Suite 213 | Minneapolis, MN 55416 | 651-265-7843 | info@svin.org
©2026 Society of Vascular and Interventional Neurology. All Rights Reserved. Site by The Lone Designer
Privacy Policy | Terms of Service | Feedback | Sitemap
As a result of GDPR, our Privacy Notice and Terms of Service have been updated to better explain our relationship with you. Please click here to review our Privacy Policies. If you wish to opt in/out of receiving SVIN communication, please login to your SVIN account and update your Contact Info settings in your Member Profile.